GSK plc
GLAXF
$26.00
$0.532.08%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 171.53% | -68.84% | 40.81% | -5.76% | 285.78% |
| Total Depreciation and Amortization | 173.53% | -183.66% | -35.72% | 49.36% | 302.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.61% | 4,250.14% | -107.50% | 208.33% | -125.50% |
| Change in Net Operating Assets | -364.30% | 181.93% | 52.03% | -38.77% | -61.79% |
| Cash from Operations | -50.20% | 1.12% | 7.01% | 94.15% | -51.65% |
| Capital Expenditure | 61.66% | -81.72% | -22.63% | -30.54% | 62.40% |
| Sale of Property, Plant, and Equipment | 106.49% | 156.45% | 0.94% | 430.31% | -98.39% |
| Cash Acquisitions | -3,155.41% | 95.07% | -28,836.49% | 99.60% | -1,114.95% |
| Divestitures | 24,257.12% | -1.36% | 103.61% | -2,869.69% | 80.33% |
| Other Investing Activities | 67.26% | 10.80% | -7.71% | -173.53% | 76.89% |
| Cash from Investing | -56.22% | 39.89% | -147.27% | 42.05% | -0.54% |
| Total Debt Issued | 117.75% | 790.00% | -112.40% | -68.95% | 54.88% |
| Total Debt Repaid | 7.59% | -27.42% | 96.06% | -627.78% | 81.27% |
| Issuance of Common Stock | 700.00% | -- | -100.00% | -83.33% | -- |
| Repurchase of Common Stock | -29.37% | 20.50% | 43.49% | -127.13% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.04% | 1.97% | -0.02% | -13.69% | 1.65% |
| Other Financing Activities | 124.07% | -109.71% | 10.43% | -47.44% | 62.68% |
| Cash from Financing | 131.59% | 35.80% | 44.04% | -393.22% | 200.21% |
| Foreign Exchange rate Adjustments | 104.85% | -168.54% | 329.06% | -150.69% | -254.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111.32% | 178.21% | 38.48% | -215.94% | 122.39% |